Back to Bills

B.C. Can Sue Vaping Firms for Health Costs

Full Title:
Vaping Product Damages and Health Care Costs Recovery Act

Summary#

This bill lets the B.C. government sue vaping companies and related firms to recover the public health costs linked to vaping. It covers past and future costs for treating disease, addiction, and other health harms tied to nicotine vaping products. It uses tools first built for tobacco lawsuits, updated for vaping.

  • Gives B.C. a direct right to sue manufacturers, wholesalers, trade groups, and marketing consultants for vaping-related harms.
  • Allows the province to claim costs for a whole population using statistics, instead of proving each person’s case one by one.
  • Lets courts split the bill among companies based on factors like market share, profits, riskiness of conduct, and how products were promoted.
  • Makes company directors and officers personally responsible if they knew about or allowed the wrongdoing.
  • Applies to nicotine devices and liquids; cannabis products are excluded. Government can add products by regulation, including nicotine pouches.
  • Protects privacy by keeping individual medical records out of court in aggregate cases, except for anonymized samples.
  • Extends the time for the government to sue and allows older cases to proceed, even if they were previously time‑barred.

What it means for you#

  • Consumers who vape

    • No direct change to what you can buy today.
    • Companies may change products, packaging, or warnings to reduce legal risk.
    • Prices could rise if firms pass lawsuit costs to customers.
  • Parents, students, and schools

    • The province can seek to recover the costs of prevention and cessation programs, including those run through schools.
    • Individual students’ identities and health records are protected in government cases that use population-level evidence.
  • People with vaping-related illness

    • Your right to sue privately is unchanged. A government lawsuit does not block or replace your own claim.
    • In government cost-recovery cases, your personal medical file usually won’t be used or shared.
  • Taxpayers and patients

    • If B.C. wins or settles cases, recovered money could offset public health spending on vaping-related care and programs.
    • If cases are unsuccessful, the province may still face legal costs.
  • Businesses (manufacturers, wholesalers, trade groups, marketing consultants)

    • Higher legal exposure for past and current conduct tied to making, promoting, or supplying nicotine vaping products.
    • Courts can hold multiple firms responsible and require any one of them to pay the full amount if they acted together, with later cost-sharing among them.
    • Directors and officers can be personally liable if they directed, allowed, or ignored the wrongdoing.
    • The government can use market share and other evidence to assign costs even when the exact source of harm is hard to trace.
    • People who, in good faith, provide information to the government for these cases are protected from being sued.

Expenses#

No publicly available information.

Proponents' View#

  • Shifts the cost of vaping-related disease from taxpayers to the industry that made and promoted the products.
  • Uses proven tools from tobacco and opioid cost-recovery laws to handle complex health harms at population scale.
  • Protects privacy by relying on statistics instead of thousands of individual medical files.
  • Personal liability for executives encourages safer products, honest marketing, and stronger compliance.
  • Lets B.C. team up with other Canadian governments in one case, improving efficiency and bargaining power.
  • Flexible rules help courts assign fair shares of costs based on sales, profits, and conduct.

Opponents' View#

  • Retroactive rules and long time limits create legal uncertainty and may be unfair to companies for older conduct.
  • Government certificates counting as final proof of costs, and presumptions that favor the province, may tilt the playing field against defendants.
  • Using population-level statistics and market share can make firms pay even when direct causation for specific patients isn’t shown.
  • Broader liability, including for consultants and directors, could chill lawful marketing and innovation.
  • Added legal risk and settlement costs may raise prices for adult consumers or push some sales to unregulated markets.